04.04.18
CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, announced today that the company has completed an initial review of safety data for its ongoing trials...
Read more16.02.18
Due to changes in data protection legislation, soon NPUK won’t be able to contact you about any of our services or activities unless you explicitly give your consent.
Read more01.02.18
The NPUK News Winter 2018 Issue is now available, featuring research and clinical trial updates, fundraising news, and much much more...
Read more24.01.18
360 Textile Technologies has announced a collaboration with Niemann-Pick UK, and will provide a donation on the sale of every pair of their waterproof, breathable knitted shoes...
Read more17.01.18
CTD Holdings’ European Clinical Trial Adopted by National Institute for Health Research of England...
Read more
